ALLIANCE A221405

Primary Category:

Cancer Control and Prevention Protocols, Treatment Protocols

Disease Category:

Adjuvant Breast, Breast

Status:

Closed

Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer

NCT#02308085

Eligible for screening study DCP 001

Effective December 31st, 2019, study A221405 is permanently closed to new patient registration.

This protocol has additional regulatory requirements to be completed prior to registering any patients at your site.  Please contact Amber Boerner at 406-969-6067 or aboerner@mtcancer.org for additional information.